Preventing Amputations: Rapid Nexus Clinical Results

At LSI, Dr. Kalmeta shares early results from Rapid Nexus’s regenerative wound care technology, highlighting that 17 amputations were prevented and 39 complex wounds were successfully closed by treating tissue surrounding the wound. This demonstrates the potential impact of Rapid Nexus’s platform on diabetic patients at risk for limb loss. Half of diabetic patients who undergo an amputation die within two years. In a recent study, Rapid Nexus Nanotech Wound Solutions, Inc. successfully prevented 17 amputations and closed 39 complex wounds by treating the tissue surrounding the affected area—stopping scheduled amputations before they were needed. This represents just a glimpse of what our regenerative technology can achieve. Watch the rest of the presentation here.